|
|
Post by johank on Oct 26, 2015 15:12:56 GMT
Volume has been very light lately. Is it just a coincidence that Mako Research is feeling some heat at the same time?
|
|
|
|
Post by thechurchmaus on Oct 26, 2015 16:03:45 GMT
they are after bigger fish now -see valeant-a classic operation.you do nothing about evil it gets more emboldened.
|
|
|
|
Post by chuck on Oct 26, 2015 21:43:20 GMT
To da moon
|
|
|
|
Post by vzveteran on Oct 28, 2015 11:55:17 GMT
|
|
|
|
Post by jckrdu on Oct 28, 2015 13:03:36 GMT
I posted the below yesterday on another thread...
Some funky after hour trades in ATHX and some other bio techs.
Just figured I'd mention it as the 350K shares recorded/bought after hours at $1.08 doesn't appear to be anything specific to ATHX, as I saw similar large blocks at around the same time (4:56 PM EST) recorded in other stocks.
|
|
|
|
Post by selluwud on Oct 28, 2015 13:30:06 GMT
Corrective journal entries made during after hours after reconciliation? |
|
|
|
Post by johank on Oct 28, 2015 15:12:39 GMT
With the low volume, and sharp increase in PPS, I suspect a hit piece to come out soon.
|
|
|
|
Post by myocata on Oct 28, 2015 18:26:53 GMT
What's prophetic statement "With the low volume, and sharp increase in PPS, I suspect a hit piece to come out soon."
From others.....
"Ocata had to halt a Phase 1/2 study investigating patient-specific iPSC-derived RPE cells in dry AMD after researchers discovered that cells bound for the second patient in the study housed six mutations, including one in oncogene. It has been determined that the mutations were not in the patient’s cells prior to reprogramming, suggesting the mutations arose during the induction process."
Signals Blog Feed | Centre for Commercialization of Regenerative Medicine
|
|
|
|
Post by actcfan on Oct 28, 2015 20:10:58 GMT
|
|
|
|
Post by johank on Oct 28, 2015 21:08:50 GMT
What's prophetic statement "With the low volume, and sharp increase in PPS, I suspect a hit piece to come out soon." From others..... "Ocata had to halt a Phase 1/2 study investigating patient-specific iPSC-derived RPE cells in dry AMD after researchers discovered that cells bound for the second patient in the study housed six mutations, including one in oncogene. It has been determined that the mutations were not in the patient’s cells prior to reprogramming, suggesting the mutations arose during the induction process." Signals Blog Feed | Centre for Commercialization of Regenerative Medicine I think this was discussed previously, the article is inaccurate; it was not Ocata that halted a study, rather Riken.
...and no hit piece yet, but it seems like something is brewing in all this silence.
|
|
|
|
Post by myocata on Oct 29, 2015 2:09:59 GMT
johank
A hit piece is coming soon.
at any rate, I looked for the comment section from the article but I can't find it. So I sent them a request to correct the article thru their contacts.
|
|
|
|
Post by selluwud on Oct 29, 2015 14:13:20 GMT
With this current little run up, I would be looking for the shorts to start buying options anytime now with a nice hit piece to push the process.
|
|
sunny
Junior Member
Posts: 57 
|
Post by sunny on Oct 29, 2015 18:13:56 GMT
|
|
|
|
Post by selluwud on Nov 4, 2015 18:01:15 GMT
 Wow, no daily discussion since Oct 29 at 2:13. Sleepy times. I found this unconfirmed CC date on my fidelity site. |
|
|
|
Post by actcfan on Nov 4, 2015 20:15:17 GMT
Wow, no daily discussion since Oct 29 at 2:13. Sleepy times. I found this unconfirmed CC date on my fidelity site. Last years Q3 call was on Monday, Nov 10th, FWIW. |
|
|
|
Post by mmeyrow on Nov 4, 2015 20:19:58 GMT
It's been going up because I sold 1000 shares from my account @4.56 that I paid $15 a share for. I wanted the loss for the year. I am sure it will go up now and we will no longer see these prices as I have a GTC order @4.35
|
|
|
|
Post by iamaverb on Nov 5, 2015 5:42:42 GMT
It's been going up because I sold 1000 shares from my account @4.56 that I paid $15 a share for. I wanted the loss for the year. I am sure it will go up now and we will no longer see these prices as I have a GTC order @4.35 Taking one for the team. |
|
|
|
Post by newceo on Nov 5, 2015 14:01:47 GMT
It warms my heart knowing when the next set of lies arrive they will be lying to Institutional investors and not a bunch of retail tools. PW has teased shareholders all year long about some BS SPA meeting that never materializes, and is famous for his Q4 to Q2, back to Q4 JV BS. After being underwater since 2007 with this investment it is doubtful the SPA nor the JV LIE will happen this year. I doubt he even mentions Phase 2 patients being injected if they even have a Q4 meeting. Would you hold a meeting if you continue to miss every projection and guidance in the history of your employment? This time the faceslap lies are for the Institutions that trusted Management's guidance.
|
|
|
|
Post by selluwud on Nov 5, 2015 16:51:26 GMT
|
|
|
|
Post by CM kipper007 on Nov 6, 2015 16:26:18 GMT
Wow, no daily discussion since Oct 29 at 2:13. Sleepy times. I found this unconfirmed CC date on my fidelity site. Last years Q3 call was on Monday, Nov 10th, FWIW. Do you think think climb is due to people hedging on news from the expected call? |
|
